You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Participants tried to classify samples based on the epigenomic impact of cigarette smoke cessation and aerosol from modified- or reduced-risk products.
Nigel Mouncey joined the JGI in March from Dow AgroSciences and is interested in broadening the user base and scope of JGI's research.
The agency has committed $11 million for the creation of a network of research centers that will use systems biology approaches to build predictive models for infectious diseases.
Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.
The consortium was launched last year as a network of research centers focused on building predictive models of cancer initiation, progression, and metastasis.
The new challenge focuses on computational methods for identifying blood gene expression signatures that can be used as markers of smoking exposure.
Up to five new grants will take a systems biology and omics approach to research the molecular interactions between pathogens and hosts.
NEW YORK (GenomeWeb) – Swiss contract research firm Intomics said today that it has inked an agreement to collaborate with Actelion Pharmaceuticals on research into neurodegenerative diseases.
NEW YORK (GenomeWeb) – Bioinformatics firm Berg today said that it will collaborate with researchers at the University of South Carolina in a search for lupus biomarkers.
NEW YORK (GenomeWeb News) – A pilot opportunity was launched on Tuesday by US and UK funding agencies to simplify the funding application process for researchers in the two countries who wish to collaborate on projects.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.
CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.
In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.